We confirmed these results in the Eμ-TCL1 transgenic mouse model, which spontaneously develops CD19+CD5+ CLL-like disease and recapitulates immune dysfunction witnessed in patients (17, 18). This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.